Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Channel One Style.
Press releases published on April 28, 2025
Alignment Healthcare to Present at the BofA Securities Healthcare Conference
GlobeNewswire
·
April 28, 2025
ORANGE, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that it will present at the BofA Securities Healthcare Conference on Wednesday, May 14, at 2:20 p.m. PDT. A webcast and replay of the …
Future Today Launches CTV Marketplace: Addressable, Privacy-Safe, and Fully Transparent
GlobeNewswire
·
April 28, 2025
MENLO PARK, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Future Today, a pioneer in delivering cutting-edge CTV ad-supported solutions, has unveiled the Future Today Marketplace, a groundbreaking solution that redefines Connected TV (CTV) advertising. The …
Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025
GlobeNewswire
·
April 28, 2025
DURHAM, N.C., April 28, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the first quarter of fiscal year 2025 …
Redwood to Highlight Logistics Digitalization at Gartner Supply Chain Symposium 2025
GlobeNewswire
·
April 28, 2025
CHICAGO, April 28, 2025 (GLOBE NEWSWIRE) -- Redwood Logistics (Redwood), one of the fastest-growing fourth-party logistics (4PL) providers in North America, will present on supply chain transformation at the Gartner Supply Chain Symposium 2025, held May 5- …
MADD Canada Cpl. Cumming’s Watch Awards Recognize Alberta Police Officers for Keeping Impaired Drivers off the Roads
GlobeNewswire
·
April 28, 2025
EDMONTON, Alberta, April 28, 2025 (GLOBE NEWSWIRE) -- During a ceremony in Edmonton, MADD Canada will present Cpl. Cumming’s Watch awards to 68 Alberta police officers for going above and beyond in removing impaired drivers from the province’s roads. …
Les prix Cpl. Cumming's Watch de MADD Canada honorent les efforts des policiers de l'Alberta pour leur lutte contre la conduite aux capacités affaiblies
GlobeNewswire
·
April 28, 2025
EDMONTON, Alberta, 28 avr. 2025 (GLOBE NEWSWIRE) -- Au cours d'une cérémonie qui se tiendra à Edmonton, MADD Canada décernera les prix Cpl. Cumming's Watch à 68 policiers qui se sont surpassés pour retirer les conducteurs aux capacités affaiblies des …
MediWound to Present New EscharEx® Data at Leading Wound Care Conferences
GlobeNewswire
·
April 28, 2025
Presentations at WHS and SAWC to highlight EscharEx’s mechanism of action, preclinical advantages over SANTYL®, and new data in treating VLUs and DFUs Findings reinforce the ongoing Phase III study in VLUs and support the planned DFU trial strategy YAVNE, …
Quanta Therapeutics Presents Late-Breaking Data for QTX3544, an Oral G12V-Preferring Multi-KRAS Inhibitor, at AACR Annual Meeting 2025
GlobeNewswire
·
April 28, 2025
- Preclinical data demonstrates synergy of QTX3544 with EGFR inhibitors, broadly enhancing anti-tumor activity - - Data supports ongoing Phase 1 clinical trial for QTX3544 as monotherapy and in combination with cetuximab in patients with KRASG12V mutations …
Calidi Biotherapeutics Announces IL15 Superagonist as First Payload to be Delivered by Systemic Antitumor Virotherapy Platform at AACR Annual Meeting
GlobeNewswire
·
April 28, 2025
SAN DIEGO, April 28, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today announced the selection of IL15 …
Global Convention 2025 Empowers Consultants to ‘Go Further’ with Exclusive Trainings, Product Announcements, and New Incentives to Drive Growth
GlobeNewswire
·
April 28, 2025
SALT LAKE CITY, April 28, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the successful conclusion …
IN8bio Unveils Promising New Data from Next Generation Gamma-Delta T Cell Engager (TCE) Platform at AACR 2025
GlobeNewswire
·
April 28, 2025
First gamma-delta (γδ) TCE to demonstrate significant γδ T cell expansion and activation, potentially offering an alternative to conventional CD3-based approaches without significant adverse events such as cytokine release syndrome (CRS) INB-600 TCE …
Colabor Announces the Date of Its First Quarter 2025 Results Conference Call
GlobeNewswire
·
April 28, 2025
SAINT-BRUNO-DE-MONTARVILLE, Quebec, April 28, 2025 (GLOBE NEWSWIRE) -- Colabor Group Inc. (TSX: GCL) (“Colabor” or the “Company”) will release its results for the first quarter ended March 22, 2025, after market close on Thursday, May 1, 2025. A conference …
Groupe Colabor annonce la date de la tenue de la téléconférence pour ses résultats du premier trimestre 2025
GlobeNewswire
·
April 28, 2025
SAINT-BRUNO-DE-MONTARVILLE, Québec, 28 avr. 2025 (GLOBE NEWSWIRE) -- Groupe Colabor Inc. (TSX : GCL) (« Colabor » ou la « Société ») divulguera ses résultats pour le premier trimestre clos le 22 mars 2025, après la fermeture des marchés, jeudi le 1er mai …
DLH to Announce Fiscal 2025 Second Quarter Financial Results
GlobeNewswire
·
April 28, 2025
ATLANTA, April 28, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to …
Impulse Dynamics®’ INTEGRA-D Trial Completes Efficacy Phase
GlobeNewswire
·
April 28, 2025
Marlton, NJ, April 28, 2025 (GLOBE NEWSWIRE) -- Impulse Dynamics® plc, a global medical device company dedicated to improving the lives of people with heart failure (HF), is proud to announce that it reached an important milestone in the INTEGRA-D™ …
Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2025 Annual Meeting
GlobeNewswire
·
April 28, 2025
New data includes real-world analyses of VOQUEZNA-treated patients in the U.S. diagnosed with gastroesophageal reflux disease (GERD) FLORHAM PARK, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical …
Alterity Therapeutics Presents ATH434-201 Phase 2 Clinical Trial Results at European MSA Symposium
GlobeNewswire
·
April 28, 2025
MELBOURNE, Australia and SAN FRANCISCO, April 28, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative …
Embecta to host Analyst and Investor Day on May 22, 2025
GlobeNewswire
·
April 28, 2025
PARSIPPANY, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will hold an Analyst and Investor Day on May 22, 2025, from 9:00 a.m. to 12:30 p.m. in …
Exodus Movement, Inc. to Announce First Quarter 2025 Results on May 12, 2025
GlobeNewswire
·
April 28, 2025
OMAHA, Neb., April 28, 2025 (GLOBE NEWSWIRE) -- Exodus Movement, Inc. (NYSE American: EXOD) ("Exodus"), a leading self-custodial cryptocurrency platform, today announced that it will release its first quarter financial results on Monday, May 12, 2025, …
BriaCell Presents Benchmark Beating Survival and Clinical Benefit at AACR 2025; Advancements in Next Generation Bria-OTS+™ Development
GlobeNewswire
·
April 28, 2025
Overall survival and clinical benefit in Phase 2 continue to outperform historical benchmarks, including very heavily pretreated patients Clinical benefit observed in 83% of evaluable patient sub-group treated with the phase 3 formulation Improved new Bria …